BOSIA, MARTA
 Distribuzione geografica
Continente #
EU - Europa 4.110
AS - Asia 3.228
NA - Nord America 2.475
SA - Sud America 571
AF - Africa 68
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.472
Nazione #
US - Stati Uniti d'America 2.338
RU - Federazione Russa 2.008
SG - Singapore 1.196
CN - Cina 1.021
IT - Italia 639
BR - Brasile 478
SE - Svezia 400
HK - Hong Kong 398
VN - Vietnam 286
RO - Romania 267
FR - Francia 170
DE - Germania 155
GB - Regno Unito 137
IN - India 96
CA - Canada 75
FI - Finlandia 61
NL - Olanda 61
ES - Italia 48
PL - Polonia 46
TR - Turchia 42
BD - Bangladesh 41
MX - Messico 38
AR - Argentina 35
IE - Irlanda 30
AT - Austria 26
JP - Giappone 26
CO - Colombia 20
ZA - Sudafrica 19
EC - Ecuador 16
PK - Pakistan 14
AU - Australia 13
EG - Egitto 13
ID - Indonesia 13
KR - Corea 12
IQ - Iraq 10
LT - Lituania 10
KE - Kenya 8
MY - Malesia 8
PH - Filippine 8
TN - Tunisia 8
UZ - Uzbekistan 8
IR - Iran 7
JM - Giamaica 7
UA - Ucraina 7
MA - Marocco 6
PT - Portogallo 6
SA - Arabia Saudita 6
BE - Belgio 5
CH - Svizzera 5
CL - Cile 5
IL - Israele 5
PE - Perù 5
PY - Paraguay 5
AZ - Azerbaigian 4
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
JO - Giordania 4
NP - Nepal 4
NZ - Nuova Zelanda 4
RS - Serbia 4
VE - Venezuela 4
BG - Bulgaria 3
GR - Grecia 3
HR - Croazia 3
HU - Ungheria 3
LB - Libano 3
OM - Oman 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
CR - Costa Rica 2
DK - Danimarca 2
ET - Etiopia 2
HN - Honduras 2
KZ - Kazakistan 2
LV - Lettonia 2
LY - Libia 2
MD - Moldavia 2
PA - Panama 2
SC - Seychelles 2
AL - Albania 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
EU - Europa 1
GT - Guatemala 1
KG - Kirghizistan 1
KI - Kiribati 1
MR - Mauritania 1
MU - Mauritius 1
NO - Norvegia 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
VG - Isole Vergini Britanniche 1
Totale 10.471
Città #
Singapore 569
Moscow 427
Hong Kong 382
San Jose 366
Ashburn 341
Dallas 225
Shanghai 199
Beijing 178
Milan 147
Hefei 136
Lauterbourg 113
New York 103
Princeton 102
Lawrence 101
Ho Chi Minh City 95
São Paulo 60
Los Angeles 59
Hanoi 58
Munich 57
Orem 50
Boardman 47
Rome 41
Helsinki 36
Warsaw 34
Chennai 33
Council Bluffs 31
Dublin 30
Atlanta 28
Montreal 28
Santa Clara 28
Denver 26
Brooklyn 25
London 25
Tokyo 23
Frankfurt am Main 19
Seattle 19
The Dalles 19
Da Nang 18
Manchester 18
Pittsburgh 18
Poplar 18
Pune 18
San Francisco 18
Stockholm 18
Turku 18
Guangzhou 17
Houston 16
Toronto 16
Amsterdam 15
Ankara 15
Nuremberg 15
Vienna 15
Istanbul 14
Boston 13
Genoa 12
Haiphong 12
Johannesburg 12
Mexico City 12
Belo Horizonte 11
Rio de Janeiro 11
Chicago 10
Phoenix 10
Secaucus 10
City of London 9
Curitiba 9
Mumbai 9
Naples 9
Turin 9
Apodaca 8
Bologna 8
Brasília 8
Brescia 8
Washington 8
Bắc Ninh 7
Cairo 7
Castano Primo 7
Dalian 7
Dhaka 7
Fortaleza 7
Guarulhos 7
Lentate sul Seveso 7
Nairobi 7
Columbus 6
Dalton 6
Florence 6
Guayaquil 6
Ottawa 6
Shenzhen 6
Tashkent 6
Tianjin 6
Xi'an 6
Bari 5
Biên Hòa 5
Campinas 5
Catania 5
Charlotte 5
Ferrara 5
Guwahati 5
Gwangjin-gu 5
Lappeenranta 5
Totale 4.887
Nome #
Clozapine to N-Desmethylclozapine ratio in treatment resistant schizophrenia: clinical implications from psychopathology to cognition 378
Schizophrenia and psychedelic state: Dysconnection versus hyper-connection. A perspective on two different models of psychosis stemming from dysfunctional integration processes 230
Assessment of pragmatic abilities and cognitive substrates (APACS) brief remote: a novel tool for the rapid and tele-evaluation of pragmatic skills in Italian 176
Functional and structural brain correlates of theory of mind and empathy deficits in schizophrenia 148
'Theory' of mind impairment in patients affected by schizophrenia and in their parents 146
M51. EFFICACY OF “PRAGMACOM TRAINING” IN SCHIZOPHRENIA: A RCT ON A NOVEL PRAGMATIC INTERVENTION 138
The cognitive architecture of verbal humor in schizophrenia 133
Valutazione del funzionamento cognitivo ‘trasferibili’ alla pratica clinica: la brief assessment of cognition scale (BACS) e la schizophrenia cognition rating scale (SCORS) 132
Cognitive Remediation for Inpatients With Schizophrenia: Effects of a Brief and Intensive Training 124
Mind the past: A systematic review on psychological autopsy 119
Adult Consequences of Neurodevelopmental Disorders 119
Get up! Functional mobility and metabolic syndrome in chronic schizophrenia: Effects on cognition and quality of life 119
It is time to address language disorders in schizophrenia: a RCT on the efficacy of a novel training targeting the pragmatics of communication (PragmaCom) 115
Clozapine tolerability in Treatment Resistant Schizophrenia: exploring the role of sex 112
The kynurenine pathway in treatment-resistant schizophrenia at the crossroads between pathophysiology and pharmacotherapy 111
Psychotic Disorders 109
Modeling the interplay of age at onset and sex on cognition in Schizophrenia 109
A leopard cannot change its spots: A novel pragmatic account of concretism in schizophrenia 109
Improving outcome of treatment-resistant schizophrenia: effects of cognitive remediation therapy 109
Deconstructing heterogeneity in schizophrenia through language: a semi-automated linguistic analysis and data-driven clustering approach 103
Cognitive reserve profiles are associated with outcome in schizophrenia 103
Communicative-pragmatic abilities mediate the relationship between cognition and daily functioning in schizophrenia 103
Combined effect of treatment-resistance and autistic traits on sociocognitive abilities in schizophrenia 101
Self-awareness of cognitive functioning in schizophrenia: Patients and their relatives 99
Disentangling Cognitive Heterogeneity in Psychotic Spectrum Disorders 98
Comprehensive dissection of prevalence rates, sex differences, and blood level-dependencies of clozapine-associated adverse drug reactions 97
Cognitive remediation in schizophrenia: What happens after 10 years? 97
Machine Learning and Criminal Justice: A Systematic Review of Advanced Methodology for Recidivism Risk Prediction 97
Eyes wide open: A systematic review of the association between insomnia and aggression in forensic contexts 96
Can patients with schizophrenia have good mentalizing skills? Disentangling heterogeneity of theory of mind 96
9-OH risperidone response in risperidone poor responders: An open study of drug response concordance 95
Cognition in Schizophrenia: Modeling the Interplay between Interleukin-1β C-511T Polymorphism, Metabolic Syndrome, and Sex 95
ADDing a piece to the puzzle of cognition in schizophrenia 94
Targeting quality of life in schizophrenia: the fil rouge between metabolic syndrome and anxiety 93
Dysconnection in schizophrenia: Filling the dots from old to new evidence 93
Catechol-O-methyltransferase (COMT) genotype biases neural correlates of empathy and perceived personal distress in schizophrenia 93
Organic Mental Disorders and Psychiatric Issues in the Elderly 91
Association study of COMT Val108/158Met polymorphism and treatment response to haloperidol, risperidone and clozapine 91
Non-Pharmacological Treatments 90
Influence of catechol-O-methyltransferase Val(158) Met polymorphism on neuropsychological and functional outcomes of classical rehabilitation and cognitive remediation in schizophrenia 90
Obsessive-compulsive symptoms moderates the effects of cognitive functioning on quality of life in clozapine-treated schizophrenia 89
Importance of the dysregulation of the kynurenine pathway on cognition in schizophrenia: a systematic review of clinical studies 89
Neuroinflammation and kynurenines in schizophrenia: Impact on cognition depending on cognitive functioning and modulatory properties in relation to cognitive remediation and aerobic exercise 89
Achieving recovery in patients with schizophrenia through psycho-social interventions: A retrospective study 87
Longitudinal course of cognition in schizophrenia: Does treatment resistance play a role? 87
Association study of GSK-3 beta-50T/C polymorphism with executive performances in schizophrenia 84
Functional benefits of co-occurring autistic symptoms in schizophrenia is delimited by symptom severity 84
Factors affecting cognitive remediation outcome in schizophrenia: The role of treatment resistance 82
Catechol-O-methyltransferase and saitohin gene polymorphism interaction: Effect on executive functions in schizophrenia 82
Association study of GSK-3 beta-50T/C polymorphism with haloperidol resistance in schizophrenia. 82
Biochemical targets of tamoxifen and lithium in an animal model of mania 82
The clock is ticking on schizophrenia: a study protocol for a translational study integrating phenotypic, genomic, microbiome and biomolecular data to overcome disability 81
Factors involved in the level of functioning of patients with schizophrenia according to latent variable modeling 76
Association study of a functional cathechol-O-methyltransferase polymorphism and cognitive rernediation in schizophrenia 76
Psychedelics and schizophrenia: a double-edged sword 76
Medium-term effectiveness of a new, prolonged-release, atypical antipsychotic: An objectives-based observational study [Effectiveness a medio termine di un nuovo antipsicotico atipico a rilascio prolungato: Uno studio osservazionale per obbiettivi] 74
Antipsychotics, metabolic syndrome and schizophrenia: investigating the role of SREBF polymorphisms 74
VALUTAZIONI DEL FUNZIONAMENTO COGNITIVO “TRASFERIBILI” ALLA PRATICA CLINICA: LA BRIEF ASSESSMENT OF COGNITION SCALE (BACS) E LA SCHIZOPHRENIA COGNITION RATING SCALE (SCORS) 74
Eyes wide open: A systematic review of the association between insomnia and aggression in forensic contexts 72
M202. SEX-RELATED DIFFERENCES IN CLOZAPINE SIDE EFFECTS IN PATIENTS WITH TREATMENT-RESISTANT SCHIZOPHRENIA 71
Is longer treatment better? A comparison study of 3 versus 6 months cognitive remediation in schizophrenia 71
HTTLPR functional polymorphism in schizophrenia: Executive functions vs. sustained attention dissociation 70
Substance-Related Disorders 68
Cognitive dysfunction and glutamate reuptake: effect of EAAT2 polymorphism in schizophrenia 68
Factors affecting cognitive remediation response in schizophrenia: The role of COMT gene and antipsychotic treatment 66
Consensus five factor PANSS for evaluation of clinical remission: effects on functioning and cognitive performances 64
Navigating the Complexity of Psychotic Disorders: A Systematic Review of EEG Microstates and Machine Learning 62
Interleukin-1 beta, cognition and metabolic syndrome in schizophrenia 62
White matter integrity, clinical symptoms and quality of life in schizophrenia: a DTI study 61
Exploring functioning in schizophrenia: Predictors of functional capacity and real-world behaviour 61
S67. TREATMENT-RESISTANCE AFFECTS LONG-TERM COGNITIVE TRAJECTORIES IN SCHIZOPHRENIA: A LONGITUDINAL STUDY 61
Combined neurocognitive and metacognitive rehabilitation in schizophrenia: Effects on bias against disconfirmatory evidence 60
Computer-aided neurocognitive remediation in schizophrenia: Durability of rehabilitation outcomes in a follow-up study 60
On the Implementation of Computerized Adaptive Observations for Psychological Assessment 60
Pragmatic abilities across symptoms dimensions in schizophrenia 59
Integrated cognitive remediation and standard rehabilitation therapy in patients of schizophrenia: Persistence after 5years 59
The role of premorbid adjustment in schizophrenia: Focus on cognitive remediation outcome 59
Daily Functioning in Schizophrenia: Is There Room for Anxiety? 59
The Influence of Premorbid Adjustment and Autistic Traits on Social Cognitive Dysfunction in Schizophrenia 59
COMT Val158Met and 5-HT1A-R-1019 C/G polymorphisms: effects on the negative symptom response to clozapine 59
Cognitive dysfunction in schizophrenia: An expert group paper on the current state of the art 59
From semantic concreteness to concretism in schizophrenia: An automated linguistic analysis of speech produced in figurative language interpretation 58
CYP450 genotypes: metabolism and efficacy of the antidepressant mirtazapine 57
Improving Cognition to Increase Treatment Efficacy in Schizophrenia: Effects of Metabolic Syndrome on Cognitive Remediation's Outcome 57
Melatonin and aggressive behavior: A systematic review of the literature on preclinical and clinical evidence 57
Exploring predictors of work competence in schizophrenia: The role of theory of mind 56
The role of genetics in cognitive remediation in schizophrenia: A systematic review 56
The association of autistic traits with Theory of Mind and its training efficacy in patients with schizophrenia 56
Determinants of patient satisfaction in clozapine users: results from the Clozapine International Consortium (CLOZIN) 55
Ten years of using the APACS test: a multistudy cross-diagnostic analysis of pragmatic profiles and their relationship with Theory of Mind 55
Schizophrenia, cannabis use and Catechol-O-Methyltransferase (COMT): Modeling the interplay on cognition 55
Epigenetics in schizophrenia and association with antipsychotic response to clozapine: preliminary findings 54
Neurobiology of cognitive remediation in schizophrenia: Effects of EAAT2 polymorphism 54
Intellectual and cognitive profiles in patients affected by schizophrenia 54
Development and Validation of a Rapid Tool to Measure Pragmatic Abilities: The Brief Assessment of Pragmatic Abilities and Cognitive Substrates (APACS Brief) 53
Evaluation of the role of HTR1A C-1019G polymorphism in antidepressant efficacy: a meta-analysis 53
Treatment-resistance as a predictor of cognitive remediation outcome in schizophrenia 52
Sustained symptomatic remission in schizophrenia: Course and predictors from a two-year prospective study 52
Weighing the role of social cognition and executive functioning in pragmatics in the schizophrenia spectrum: A systematic review and meta-analysis 51
Combined social cognitive and neurocognitive rehabilitation strategies in schizophrenia: neuropsychological and psychopathological influences on Theory of Mind improvement. 51
Totale 8.705
Categoria #
all - tutte 58.301
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.301


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202284 0 0 0 20 8 4 2 6 12 6 13 13
2022/2023792 240 133 58 7 47 110 34 52 50 15 23 23
2023/2024579 36 37 72 63 62 82 12 51 2 25 29 108
2024/20252.539 272 55 70 125 95 190 497 166 388 272 202 207
2025/20266.603 550 463 271 829 638 194 736 468 1.852 410 192 0
Totale 10.642